<code id='C133F88BF0'></code><style id='C133F88BF0'></style>
    • <acronym id='C133F88BF0'></acronym>
      <center id='C133F88BF0'><center id='C133F88BF0'><tfoot id='C133F88BF0'></tfoot></center><abbr id='C133F88BF0'><dir id='C133F88BF0'><tfoot id='C133F88BF0'></tfoot><noframes id='C133F88BF0'>

    • <optgroup id='C133F88BF0'><strike id='C133F88BF0'><sup id='C133F88BF0'></sup></strike><code id='C133F88BF0'></code></optgroup>
        1. <b id='C133F88BF0'><label id='C133F88BF0'><select id='C133F88BF0'><dt id='C133F88BF0'><span id='C133F88BF0'></span></dt></select></label></b><u id='C133F88BF0'></u>
          <i id='C133F88BF0'><strike id='C133F88BF0'><tt id='C133F88BF0'><pre id='C133F88BF0'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:95
          Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT
          Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

          WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

          The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

          advertisement

          Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          To bolster infectious disease surveillance, genomics powerhouses team up
          To bolster infectious disease surveillance, genomics powerhouses team up

          TuliodeOliveiraleadsSouthAfrica’sCentreforEpidemicResponseandInnovation.CourtesyCERI@SULONDON—Twores

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          Dana Farber says 6 studies to be retracted and 31 corrected

          CraigF.Walker/TheBostonGlobeAreviewofallegeddatamanipulationinstudiesinvolvingfourtopscientistsatDan